We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Friday, July 01, 2022
The Food and Drug Administration for the first time cleared the marketing of products from a biotech food animal, approving beef cattle that are genetically altered to be more tolerant of hot weather.
President Joe Biden has chosen Robert Califf to lead the Food and Drug Administration, which would give the cardiologist and professor a second stint at the agency's helm.
Streamlined regulations, enforcement of trade agreements, and increased funding for university research are all needed to advance innovation in biotechnology, witnesses and House Agriculture Committee members said at a hearing Tuesday.
Six groups have filed suit against the Agriculture Department over regulations the Trump administration issued last year to streamline the regulation of gene-edited crop traits and allow companies to decide whether their products need USDA approval.
Lawmakers can now turn their eyes toward next Wednesday when Joe Biden will be inaugurated as president after Donald Trump was impeached by the House for a second time. The Senate won’t take up the impeachment before Trump leaves office.
The Environmental Protection Agency is proposing to exempt from its regulation some biotech crops that are genetically engineered to be toxic to damaging insects and other plant pests.
In this opinion piece, Liam Condon with Bayer Ag discusses what makes a resilient food system and what tools are needed to meet the global challenge of feeding the world without starving the planet.
The Agriculture Department has finalized a sweeping overhaul of its approval process for biotech crops that will exempt some gene modifications from regulation and allow developers to decide on their own whether their products qualify.
Agriculture Secretary Sonny Perdue, who insists he’s optimistic about a farm economy rebound this year, faces a pair of congressional hearings this week where he is certain to face further grilling about trade prospects and future of the Market Facilitation Program.
The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, but the industry is backing the Agriculture Department's push to take over some of FDA's oversight role.
